'One Test, Eleven Answers' targets genetic diseases
About one in five Ashkenazi Jews is a carrier of one of 11 life-threatening diseases for which screening tests are now available. That's the message of a new screening education campaign called "One Test, Eleven Answers" launched recently by the Genetic Disease Foundation (GDF).
About one in five Ashkenazi Jews is a carrier of one of 11 life-threatening diseases for which screening tests are now available. That's the message of a new screening education campaign called "One Test, Eleven Answers" launched recently by the Genetic Disease Foundation (GDF).
The campaign, aimed at couples in which one or both members is of Jewish descent, explains that only one blood sample is necessary from each individual to perform all 11 tests. The diseases that can be identified prior to or early in pregnancy are Bloom Syndrome, Canavan Disease, Cystic Fibrosis, Familial Dysautonomia, Fanconi Anemia Type C, Gaucher Disease, Glycogen Storage Disease Type 1A, Maple Syrup Urine Disease, Mucolipidosis IV, Type A Niemann-Pick Disease, and Tay-Sachs Disease.
The GDF, a non-profit organization established in 1997 by patients, parents, and families, is dedicated to the research, treatment, and cure of all genetic diseases. For more information, call 212-659-6704 or log on to http://www.geneticdisease.org/.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
